|
20 Sep 2025 |
Zydus Lifesciences
|
Consensus Share Price Target
|
1037.30 |
1011.50 |
- |
-2.49 |
hold
|
|
|
|
|
29 Apr 2023
|
Zydus Lifesciences
|
BP Wealth
|
1037.30
|
597.00
|
519.90
(99.52%)
|
Target met |
Buy
|
|
|
|
|
22 Mar 2023
|
Zydus Lifesciences
|
Sharekhan
|
1037.30
|
572.00
|
478.65
(116.71%)
|
Target met |
Buy
|
|
|
|
|
17 Feb 2023
|
Zydus Lifesciences
|
Geojit BNP Paribas
|
1037.30
|
528.00
|
470.65
(120.40%)
|
Target met |
Accumulate
|
|
|
|
|
06 Feb 2023
|
Zydus Lifesciences
|
Prabhudas Lilladhar
|
1037.30
|
480.00
|
470.15
(120.63%)
|
Target met |
Accumulate
|
|
|
|
|
06 Feb 2023
|
Zydus Lifesciences
|
ICICI Securities Limited
|
1037.30
|
482.00
|
434.65
(138.65%)
|
Target met |
Accumulate
|
|
|
Zydus Lifesciences’ (Zydus) reported Q3FY23 performance exceeded our estimates on all fronts. Revenues grew 19.4% YoY to Rs43.6bn (I-Sec: Rs40.7bn) driven by India and US markets.
|
|
04 Feb 2023
|
Zydus Lifesciences
|
ICICI Direct
|
1037.30
|
500.00
|
434.65
(138.65%)
|
Target met |
Buy
|
|
|
|
|
04 Feb 2023
|
Zydus Lifesciences
|
Motilal Oswal
|
1037.30
|
460.00
|
434.00
(139.01%)
|
Target met |
Neutral
|
|
|
|
|
02 Jan 2023
|
Zydus Lifesciences
|
Ashika Research
|
1037.30
|
480.00
|
420.10
(146.92%)
|
Target met |
Buy
|
|
|
|
|
14 Nov 2022
|
Zydus Lifesciences
|
ICICI Direct
|
1037.30
|
480.00
|
423.80
(144.76%)
|
Target met |
Hold
|
|
|
|
|
14 Nov 2022
|
Zydus Lifesciences
|
Prabhudas Lilladhar
|
1037.30
|
465.00
|
416.75
(148.90%)
|
Target met |
Accumulate
|
|
|
|